2022
Post-9/11 deployment history and the incidence of breast cancer among women veterans
Gaffey A, Han L, Ramsey C, Skanderson M, Dziura J, Driscoll M, Burg M, Brandt C, Bastian L, Haskell S. Post-9/11 deployment history and the incidence of breast cancer among women veterans. Annals Of Epidemiology 2022, 77: 98-102. PMID: 36470323, DOI: 10.1016/j.annepidem.2022.11.010.Peer-Reviewed Original ResearchConceptsOEF/OIF deploymentBreast cancerWomen veteransHealthcare utilizationHormone replacement therapy useRetrospective cohort studyVeterans Affairs (VA) careHealthy soldier effectOEF/OIFCohort studyTherapy useBC incidenceHormonal contraceptivesLifestyle factorsPrimary careBC diagnosisLower incidenceOperations Enduring Freedom/Iraqi FreedomWomenIncidenceGreater likelihoodIraqi FreedomVeteransCancerCare
2008
Predictors of Perceived Susceptibility of Breast Cancer and Changes Over Time: A Mixed Modeling Approach
McQueen A, Swank PR, Bastian LA, Vernon SW. Predictors of Perceived Susceptibility of Breast Cancer and Changes Over Time: A Mixed Modeling Approach. Health Psychology 2008, 27: 68-77. PMID: 18230016, PMCID: PMC2819176, DOI: 10.1037/0278-6133.27.1.68.Peer-Reviewed Original ResearchConceptsBreast cancerBreast symptomsCancer worryGreater cancer worryUS women veteransIntervention trialsMixed model analysisHealth behaviorsWomen veteransPercent riskHealth statusCancerPerceived susceptibilityGroup-level changesSingle-item measureAssess differencesPredictorsSymptomsEffect sizeIndividual variabilityDependent measuresGood targetConsistent predictorSusceptibilityModel effect sizes
2002
Hormone replacement therapy and the risk of death from breast cancer: A systematic review
Nanda K, Bastian LA, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: A systematic review. American Journal Of Obstetrics And Gynecology 2002, 186: 325-334. PMID: 11854659, DOI: 10.1067/mob.2002.121077.Peer-Reviewed Original ResearchConceptsHormone replacement therapy usersHormone replacement therapyRisk of deathReplacement therapyBreast cancerTherapy usersCombined hormone replacement therapyRetrievable risk estimatesBreast cancer deathsCase-control studyRecency of useAscertainment of exposurePotential confoundersCancer deathRelative riskInclusion criteriaObservational studyHistologic conditionControl groupSystematic reviewProlonged durationTherapyProlonged useCancerRisk estimates
2001
Women's Interest in Chemoprevention for Breast Cancer
Bastian L, Lipkus I, Kuchibhatla M, Weng H, Halabi S, Ryan P, Skinner C, Rimer B. Women's Interest in Chemoprevention for Breast Cancer. JAMA Internal Medicine 2001, 161: 1639-1644. PMID: 11434796, DOI: 10.1001/archinte.161.13.1639.Peer-Reviewed Original ResearchConceptsBreast cancer riskBreast cancerCancer riskGail scoreObjective breast cancer riskMammography decision aidObjective risk factorsDevelopment of cancerAbsolute riskRisk factorsChemopreventive agentsChemopreventionCancerComparative riskTelephone interviewsTamoxifen citrateDrugsWomenRiskNatural agentsCommunity sampleDecision aidScoresTherapyAgents
1998
Differences in Providers' Beliefs about Benefits and Risks of Hormone Replacement Therapy in Managed Care
Exline J, Siegler I, Bastian L. Differences in Providers' Beliefs about Benefits and Risks of Hormone Replacement Therapy in Managed Care. Journal Of Women's Health 1998, 7: 879-884. PMID: 9785314, DOI: 10.1089/jwh.1998.7.879.Peer-Reviewed Original ResearchConceptsHormone replacement therapyRisks of HRTReplacement therapyBreast cancerFamily physiciansBenefits of HRTProviders' beliefsProvider-patient discussionsGender of physiciansHealth maintenance organizationCross-sectional surveyThromboembolic eventsHeart diseasePhysicians' beliefsPhysician genderCare settingsFemale providersAlzheimer's diseasePhysician assistantsFemale physiciansMaintenance organizationPhysiciansDiseaseManaged CareRiskPromoting Informed Decision Making: Hormone Replacement Therapy
Bastian L, Couchman G, Rimer B, McBride C, Sutton L, Siegler I. Promoting Informed Decision Making: Hormone Replacement Therapy. Cancer Treatment And Research 1998, 97: 129-147. PMID: 9711414, DOI: 10.1007/978-0-585-30498-4_10.Peer-Reviewed Original ResearchConceptsHormonal replacement therapyReplacement therapyBreast cancerHormone replacement therapyRisk of cancerHRT useMenopausal symptomsMost gynecologistsHeart diseaseHigh riskNumber of womenAverage life expectancyCancerCancer issuesLife expectancyWomenMenopausePatientsTherapyRiskOsteoporosisGynecologistsSymptomsDiseasePhysiciansBreast Cancer Practice Patterns at VA Hospitals: Implications for Future Research
Hynes D, Hines E, Bastian L. Breast Cancer Practice Patterns at VA Hospitals: Implications for Future Research. Cancer Treatment And Research 1998, 97: 149-158. PMID: 9711415, DOI: 10.1007/978-0-585-30498-4_11.Peer-Reviewed Original ResearchConceptsVA hospitalsHealth care servicesWomen veteransBreast cancerCancer-related admissionsWomen Veteran populationWomen's health care servicesBreast cancer careCancer incidence estimatesBreast cancer screeningCancer careCancer screeningCancer incidencePractice patternsIncidence estimatesFiscal year 1994General populationInpatient servicesVeteran populationTreatment servicesCare servicesFemale veteransHospitalVeteransWomen
1997
Perceptions of Menopausal Stage and Patterns of Hormone Replacement Therapy Use
Bastian L, Couchman G, Rimer B, McBride C, Feaganes J, Siegler I. Perceptions of Menopausal Stage and Patterns of Hormone Replacement Therapy Use. Journal Of Women's Health 1997, 6: 467-475. PMID: 9279835, DOI: 10.1089/jwh.1997.6.467.Peer-Reviewed Original ResearchConceptsHormone replacement therapyUse of HRTHRT useStage of menopauseMenopausal stagePatient characteristicsHormone replacement therapy useCohort of womenWomen's perceptionsLogistic regression modelsBilateral oophorectomyMenopausal statusIndependent predictorsTherapy useReplacement therapyPelvic examinationOvarian cancerBreast cancerFamily historyMenopauseAverage agePhysical exerciseYoung womenWomenOverall rate